Unit of Legal Medicine, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Cardiovascular Pathology Unit, Division of Pathology, IRCCS S.Orsola Hospital and University of Bologna, Bologna, Italy.
Forensic Sci Int. 2021 Nov;328:111004. doi: 10.1016/j.forsciint.2021.111004. Epub 2021 Sep 20.
A 55-year-old man affected by a psychotic disorder suddenly died during a quarrel with his father. The autopsy excluded traumatic causes of death, and the cardiac examination identified a severe cardiomegaly with biventricular dilatation of very likely multifactorial origin. Toxicological and pharmacogenetic analyses excluded a fatal intoxication and identified the presence of the antipsychotic drug fluphenazine in the therapeutic range in a normal metabolizer. The screening for genetic variations highlighted a novel heterozygous single-nucleotide variant in the exon 36: c 0.4750C>A (p.Pro1584Thr) of the Ryanodine Receptor Type 2 (RYR2) gene. The mutation detected can be classified as Likely Pathogenic according to the American College of Medical Genetics and Genomics (ACMG) criteria. RYR2 variation has been associated to catecholaminergic polymorphic ventricular tachycardia (CPVT), a disease currently recognized as one of the most malignant cardiac channelopathies, expressed mostly in young patients, normally in the absence of structural heart disease. The victim late middle age, compared to juvenile onset of CPVT reported in literature, his clinical history, his structurally altered heart, circumstances at death and the absence of phenotype-related variations of dilated cardiomyopathy genes, suggested that the fatal arrhythmia could have been caused by an acquired form of dilated cardiopathy/cardiomyopathy. However, the contribution of the genetic variant to death cannot be completely ruled out, since the significance of a VUS or of a novel variant depends on the data available at the time of investigation, and should be periodically evaluated. We discuss the contribution of the structural alteration and of the variant detected, as well as the role of the molecular autopsy in forensic examination, which can make a significant contribution for inferring both cause and manner of death.
一位 55 岁的男性精神病患者在与父亲争吵时突然死亡。尸检排除了创伤性死因,心脏检查发现严重的心肌肥大,双侧心室扩张,极有可能是多因素引起的。毒理学和药物遗传学分析排除了致命性中毒,并在一个正常代谢者的治疗范围内发现了抗精神病药物氟奋乃静。基因变异筛查突出了 Ryanodine Receptor Type 2 (RYR2) 基因外显子 36 中 c 0.4750C>A (p.Pro1584Thr) 的新型杂合单核苷酸变异。根据美国医学遗传学与基因组学学院 (ACMG) 的标准,检测到的突变可以归类为可能致病。RYR2 变异与儿茶酚胺多形性室性心动过速 (CPVT) 有关,CPVT 是目前公认的最恶性的心脏通道病之一,主要发生在年轻患者,通常在没有结构性心脏病的情况下。与文献中报道的青少年起病 CPVT 相比,受害者为中老年,结合其临床病史、结构改变的心脏、死亡时的情况以及扩张型心肌病基因无表型相关变异,提示致命性心律失常可能是获得性扩张性心脏病/心肌病引起的。然而,由于 VUS 或新型变异的意义取决于调查时的可用数据,因此不能完全排除遗传变异对死亡的贡献,应定期评估。我们讨论了结构改变和检测到的变异的贡献,以及分子尸检在法医检查中的作用,这可以为推断死因和死亡方式做出重要贡献。